ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate

ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate manufacturers

  • SAD-448
  • SAD-448 pictures
  • $2580.00
  • 2026-05-11
  • CAS:581106-09-4
  • Purity:
  • Supply Ability: 10g
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate Basic information
Product Name:ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate
Synonyms:ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate;SAD 448;SAD448;SAD-448;SAD 448,SAD448
CAS:581106-09-4
MF:C24H28N4O8S
MW:532.56612
EINECS:
Product Categories:
Mol File:581106-09-4.mol
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate Structure
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate Chemical Properties
Safety Information
MSDS Information
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate Usage And Synthesis
UsesSAD448 is a CB1 and CB2 receptor agonist. SAD448 can lower intraocular pressure (IOP)[1].
References[1] Pryce G, et al. Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists. FASEB J. 2014 Jan;28(1):117-30. DOI:10.1096/fj.13-239442
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate Preparation Products And Raw materials
Tag:ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate(581106-09-4) Related Product Information
ethyl 2-[({[(2-hydroxyethyl)aMino]carbonyl}oxy)Methyl]-5,7-diMethyl-3-{2-[(MethylaMino)sulfonyl]phenyl}-4-oxo-3,4-dihydroquinazoline-6-carboxylate 2-Linoleoyl-rac-glycerol N-[[[[(4S)-3-(4-Chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[[4-(trifluoromethyl)phenyl]sulfonyl]amino]methylene]amino]iminomethyl]acetamide 1-(2,3-Dichlorobenzoyl)-5-methoxy-2-methyl-3-[2-(4-morpholinyl)ethyl]-1H-indole Linoleoylethanolamide Rimonabant